Macedonian Journal of Medical Sciences
[International, Peer Reviewed]

About MJMS

Our policies

MJMS Online

For contributors

Services

Why publish in MJMS?
Editors
Boards
Indexing
Membership
Evaluation

Editorial & publishing policies
Competing interests policy 
Open access
Open access license

Publication fee
Reviewer guidelines

Online first
Current issue
Journal archive

Online first fact sheet
Free Registration
Contact

Guidelines  [pdf]
Online submission
Help for authors
Cover letter
Reviewers of MJMS

Reviewers Summary

Transliteration
Subscriptions

Advertising
Reprints and permissions
Resources
ICMJE Disclosure Form

 

Macedonian Journal of Medical Sciences. 2011 Dec 15; 4(4):408-410.

http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0194

Case Report

 

Fatal Sepsis Due to Stenotrophomonas Maltophilia in Stem Cell Recipient – Case Report
 

Zlate Stojanoski


University Clinic of Hematology, Faculty of Medicine, University “Ss Cyril and Methodius”, Skopje, Republic of Macedonia

 

Abstract

 

 

Background: Infections are frequent cause of further morbidity and mortality in stem cells recipients. Infection-related mortality is mainly due to severe bacterial sepsis, pneumonia and fungal infections.

Case Report: We report a 60 years old patient with AML. In the complete remission he is received high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. The patient was treated in sterile room, conditioned with HEPA filters. Antibiotic prophylaxis regimen consisted Ciprofloxacin 1.0 gr/day, Itraconazol 400 mg/day, Acyclovir 1500 mg/day, and Immunoglobulins IV 0.1 mg/kg once per week. From day +5 patient became febrile (Ne<0.5 x 103/mL). First line antibiotic regimen consisted third-generation anti-pseudomonal cephalosporine and amynoglicoside during a 72 h, but with no response. As a second line antibiotic therapy was introduced Vancomicyn 2.0 gr/day. On day +10 from blood culture and urine culture was isolated Stenotrophomonas maltophillia with in vitro succeptibilities only to Ciprofloxacin (+3). Co-trimoxasole and again Ciprofloxacin in maximal doses was administered, but patient deteriorate, and in sepsis with signes of endotoxic shock he die on day +15.

Conclusion: Despite use of broad-spectrum antibiotics as prophylaxis, Gram-negative bacteria are still potentially fatal for immunocompromised patients. Microbiological monitoring on local microflora is mandatory for all transplant centers and intensive care units.

...................

Citation: Stojanoski Z. Fatal Sepsis Due to Stenotrophomonas Maltophilia in Stem Cell Recipient – Case Report. Maced J Med Sci. 2011 Dec 15; 4(4):408-410. http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0194.
Key words: infective; complications; stem; cell; transplantation.
Correspondence: Dr. Zlate Stojanoski. University Clinic of Hematology, Faculty of Medicine, University “Ss Cyril and Methodius”, Skopje, Republic of Macedonia. E-mail: stojanoskiza@mt.net.mk
Received: 30-Jun-2011; Revised: 29-Sep-2011; Accepted: 01-Oct-2011; Online first: 13-Oct-2011
Copyright: © 2011 Stojanoski Z. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing Interests: The author have declared that no competing interests exist.
 

 

< Previous | Next Article >

Table of contents

 

This Article (free)

Abstract

Full text (html)

Full text (pdf)

Full text OnlineFirst (pdf)

Citations

- DOAJ

- Index Copernicus

- Socol@r

Google Scholar

- Stojanoski Z

PubMed

- Stojanoski Z

 


Publication of the MJMS is supported by the Macedonian Ministry of Education and Sciences. Publisher: Institute of Immunobiology and Human GeneticsSkopje, Republic of Macedonia.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

MJMS Print (ISSN 1857-5749) is an international peer-reviewed, Open Access journal published four times per year. MJMS Online (ISSN 1857-5773) offers free access to all articles.


Creative Commons Attribution LicenseAll site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.